[1]
“Dual-Triggered PLGA Microspheres of Dapagliflozin: Ph + Enzyme Responsive for Colon-Targeted Delivery in IBD + Type 2 Diabetes Mellitus Patients”, Int. J. Res. Pharm. Sci. Technol., vol. 9, no. 3, Aug. 2026, doi: 10.33974/s5xmsa31.